Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Whooping cough and Parkinson's disease. The Europarkinson Preparatory Activity Research Group.

de Pedro-Cuesta J, Gudmundsson G, Abraira V, Gudmundsson G, Löve A, Tulinius H, Veiga J, Almazán J, Petersen IJ.

Int J Epidemiol. 1996 Dec;25(6):1301-11.

PMID:
9027539
2.

High levodopa use in periodically time-clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology? Europarkinson Preparatory Activity Research Group.

de Pedro-Cuesta J, Petersen IJ, Stawiarz L, Gudmundsson G, Gudmundsson G, Almazán J, Tulinius H, Johansson H.

Acta Neurol Scand. 1995 Feb;91(2):79-88.

PMID:
7785429
3.

High prevalence of Parkinson's disease in the Faroe Islands.

Wermuth L, Joensen P, Bünger N, Jeune B.

Neurology. 1997 Aug;49(2):426-32.

PMID:
9270572
4.
5.

Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.

Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH.

Am J Med Genet. 1999 Dec 15;88(6):742-9.

PMID:
10581500
6.

Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.

Goldsmith JR, Herishanu YO, Podgaietski M, Kordysh E.

Environ Res. 1997;73(1-2):156-61.

PMID:
9311541
7.

Levodopa-dyskinesia incidence by age of Parkinson's disease onset.

Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE.

Mov Disord. 2005 Mar;20(3):342-4.

PMID:
15580606
8.

Tracking of overweight from early childhood to adolescence in cohorts born 1988 and 1994: overweight in a high birth weight population.

Johannsson E, Arngrimsson SA, Thorsdottir I, Sveinsson T.

Int J Obes (Lond). 2006 Aug;30(8):1265-71. Epub 2006 Feb 21.

PMID:
16491112
9.

[Tuberculosis in Japan at present and in near future].

Nagayama N.

Kekkaku. 2001 Aug;76(8):571-9. Japanese.

PMID:
11558136
10.

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.

de Greeff SC, Mooi FR, Schellekens JF, de Melker HE.

Pediatr Infect Dis J. 2008 Mar;27(3):218-23. doi: 10.1097/INF.0b013e318161a2b9.

PMID:
18277916
11.

Prevalence of Parkinson's disease in lower Aragon, Spain.

Errea JM, Ara JR, Aibar C, de Pedro-Cuesta J.

Mov Disord. 1999 Jul;14(4):596-604. Review.

PMID:
10435496
12.

Parkinson's disease incidence: magnitude, comparability, time trends.

de Pedro-Cuesta J, Stawiarz L.

Acta Neurol Scand. 1991 Nov;84(5):382-8. Review.

PMID:
1776385
13.

Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.

Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D.

Pediatrics. 2006 Jul;118(1):e139-50.

PMID:
16818529
14.

Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.

Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.

Pediatrics. 2005 Aug;116(2):e285-94.

PMID:
16061582
15.

[Analysis of mortality in cancer of the large intestine in a cohort group in Serbia from 1971 to 1996].

Gajić-Veljanoski O, Jarebinski M, Jovićević-Bekić A, Pekmezović T.

Srp Arh Celok Lek. 2002 May-Jun;130(5-6):173-7. Serbian.

16.

Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.

Langley JM, Halperin SA, Boucher FD, Smith B; Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC).

Pediatrics. 2004 Jul;114(1):e96-101.

PMID:
15231980
17.

Type 1 diabetes in Yorkshire, UK: time trends in 0-14 and 15-29-year-olds, age at onset and age-period-cohort modelling.

Feltbower RG, McKinney PA, Parslow RC, Stephenson CR, Bodansky HJ.

Diabet Med. 2003 Jun;20(6):437-41.

PMID:
12786676
18.

[Effect of birth cohort, period of diagnosis and age on cancer incidence in Navarra, 1973-1997].

González Diego P, Jiménez Buñuales MT, Viñes JJ.

An Sist Sanit Navar. 2005 Sep-Dec;28(3):389-402. Spanish.

19.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
20.

Which risk factors predict the levodopa response in fluctuating Parkinson's disease?

Horstink MW, Zijlmans JC, Pasman JW, Berger HJ, Korten JJ, van 't Hof MA.

Ann Neurol. 1990 May;27(5):537-43.

PMID:
2360795

Supplemental Content

Support Center